These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial. Polgár C, Ott OJ, Hildebrandt G, Kauer-Dorner D, Knauerhase H, Major T, Lyczek J, Guinot JL, Dunst J, Miguelez CG, Slampa P, Allgäuer M, Lössl K, Polat B, Kovács G, Fischedick AR, Fietkau R, Resch A, Kulik A, Arribas L, Niehoff P, Guedea F, Schlamann A, Pötter R, Gall C, Uter W, Strnad V, Groupe Européen de Curiethérapie of European Society for Radiotherapy and Oncology (GEC-ESTRO). Lancet Oncol; 2017 Feb; 18(2):259-268. PubMed ID: 28094198 [Abstract] [Full Text] [Related]
8. Should ductal carcinoma-in-situ (DCIS) be removed from the ASTRO consensus panel cautionary group for off-protocol use of accelerated partial breast irradiation (APBI)? A pooled analysis of outcomes for 300 patients with DCIS treated with APBI. Vicini F, Shah C, Ben Wilkinson J, Keisch M, Beitsch P, Lyden M. Ann Surg Oncol; 2013 Apr; 20(4):1275-81. PubMed ID: 23054123 [Abstract] [Full Text] [Related]
9. Targeted Intraoperative Radiotherapy for the Management of Ductal Carcinoma In Situ of the Breast. Rivera R, Banks A, Casillas-Lopez A, Rashtian A, Lewinsky B, Sheth P, Hovannesian-Larsen L, Brousseau D, Iyengar G, Holmes DR. Breast J; 2016 Apr; 22(1):63-74. PubMed ID: 26534876 [Abstract] [Full Text] [Related]
14. Five-year results of a prospective clinical trial investigating accelerated partial breast irradiation using 3D conformal radiotherapy after lumpectomy for early stage breast cancer. Horst KC, Fasola C, Ikeda D, Daniel B, Ognibene G, Goffinet DR, Dirbas FM. Breast; 2016 Aug; 28():178-83. PubMed ID: 27322859 [Abstract] [Full Text] [Related]
17. Long-term followup of breast preservation by re-excision and balloon brachytherapy after ipsilateral breast tumor recurrence. Trombetta M, Hall M, Julian TB. Brachytherapy; 2014 Aug; 13(5):488-92. PubMed ID: 24950822 [Abstract] [Full Text] [Related]
18. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy. Vargas C, Kestin L, Go N, Krauss D, Chen P, Goldstein N, Martinez A, Vicini FA. Int J Radiat Oncol Biol Phys; 2005 Dec 01; 63(5):1514-21. PubMed ID: 16005576 [Abstract] [Full Text] [Related]
19. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation. Solin LJ, McCormick B, Recht A, Haffty BG, Taylor ME, Kuske RR, Bornstein BA, McNeese M, Schultz DJ, Fowble BL, Barrett W, Yeh IT, Kurtz JM, Amalric R, Fourquet A. Cancer J Sci Am; 1996 Dec 01; 2(3):158-65. PubMed ID: 9166516 [Abstract] [Full Text] [Related]
20. Five year outcome of 145 patients with ductal carcinoma in situ (DCIS) after accelerated breast radiotherapy. Ciervide R, Dhage S, Guth A, Shapiro RL, Axelrod DM, Roses DF, Formenti SC. Int J Radiat Oncol Biol Phys; 2012 Jun 01; 83(2):e159-64. PubMed ID: 22579378 [Abstract] [Full Text] [Related] Page: [Next] [New Search]